Interleukin-1R antagonist gene and pre-natal smoke exposure are associated with childhood asthma

European Respiratory Journal

Volumn 29, Issue 3, 2007, Pages 502-508

  Ramadas, R A ^a   Sadeghnejad, A ^b   Karmaus, W ^b   Arshad, S H ^c   Matthews, S ^c   Huebner, M ^a   Kim, D Y ^a   Ewart, S L ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Asthma; Genetic associtaion; Interleukin 1 receptor anatgonist; Interleukin 1 receptor antagonist gene; Maternal smoking; Smoking

Indexed keywords

GLYCINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; ENVIRONMENTAL EXPOSURE; FEMALE; FORCED EXPIRATORY VOLUME; GENE INTERACTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MATERNAL SMOKING; PHENOTYPE; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TOBACCO; UNITED KINGDOM;

ASTHMA; BRONCHIAL HYPERREACTIVITY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LINKAGE DISEQUILIBRIUM; LONGITUDINAL STUDIES; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RISK; TOBACCO SMOKE POLLUTION; VITAL CAPACITY;

EID: 33847750807     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00029506     Document Type: Article

References (50)

1. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001; 344: 350-362.
2. Frew AJ. GA2LEN-The Global Allergy and Asthma European Network. Clin Exp Allergy 2005; 35: 122-125.
3. Howard TD, Postma DS, Hawkins GA, et al. Fine mapping of an IgE-controlling gene on chromosome 2q: analysis of CTLA4 and CD28. J Allergy Clin Immunol 2002; 110: 743-751.
4. Postma DS, Meyers DA, Jongepier H, Howard TD, Koppelman GH, Bleecker ER. Genomewide screen for pulmonary function in 200 families ascertained for asthma. Am J Respir Crit Care Med 2005; 172: 446-452.
5. Evans DM, Zhu G, Duffy DL, Montgomery GW, Frazer IH, Martin NG. Major quantitative trait locus for eosinophil count is located on chromosome 2q. J Allergy Clin Immunol 2004; 114: 826-830.
6. A genome-wide search for asthma susceptibility loci in ethnically diverse populations. The Collaborative Study on the Genetics of Asthma (CSGA). Nat Genet 1997; 15: 389-392.
7. Wills-Karp M, Ewart SL. Time to draw breath: asthma-susceptibility genes are identified. Nat Rev Genet 2004; 5: 376-387.
8. Ewart SL, Kuperman D, Schadt E, et al. Quantitative trait loci controlling allergen-induced airway hyperresponsiveness in inbred mice. Am J Respir Cell Mol Biol 2000; 23: 537-545.
9. Nakae S, Komiyama Y, Yokoyama H, et al. IL-1 is required for allergen-specific Th2 cell activation and the development of airway hypersensitivity response. Int Immunol 2003; 15: 483-490.
10. Park JW, Taube C, Swasey C, et al. Interleukin-1 receptor antagonist attenuates airway hyperresponsiveness following exposure to ozone. Am J Respir Cell Mol Biol 2004; 30: 830-836.
11. Selig W, Tocker J. Effect of interleukin-1 receptor antagonist on antigen-induced pulmonary responses in guinea pigs. Eur J Pharmacol 1992; 213: 331-336.
12. Tillie-Leblond I, Pugin J, Marquette CH, et al. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 1999; 159: 487494.
13. Okada S, Inoue H, Yamauchi K, et al. Potential role of interleukin-1 in allergen-induced late asthmatic reactions in guinea pigs: suppressive effect of interleukin-1 receptor antagonist on late asthmatic reaction. J Allergy Clin Immunol 1995; 95: 1236-1245.
14. Gohlke H, Illig T, Bahnweg M, et al. Association of the interleukin-1 receptor antagonist gene with asthma. Am J Respir Crit Care Med 2004; 169: 1217-1223.
15. Karjalainen J, Joki-Erkkila VP, Hulkkonen J, et al. The IL1A genotype is associated with nasal polyposis in asthmatic adults. Allergy 2003; 58: 393-396.
16. Pessi T, Karjalainen J, Hulkkonen J, Nieminen MM, Hurme M. A common IL-1 complex haplotype is associated with an increased risk of atopy. J Med Genet 2003; 40: e66.
17. Pattaro C, Heinrich J, Werner M, Marco R, Wjst M. Association between interleukin-1 receptor antagonist gene and asthma-related traits in a German adult population. Allergy 2006; 61: 239-244.
18. Wardlaw AJ, Silverman M, Siva R, Pavord ID, Green R. Multi-dimensional phenotyping: towards a new taxonomy for airway disease. Clin Exp Allergy 2005; 35: 1254-1262.
19. Martinez FD. Links between pediatric and adult asthma. J Allergy Clin Immunol 2001; 107: Suppl. 5, S449-S455.
20. Vonk JM, Boezen HM. Predicting adult asthma in childhood. Curr Opin Pulm Med 2006; 12: 4247.
21. Szefler SJ. Challenges in assessing outcomes for pediatric asthma. J Allergy Clin Immunol 2001; 107: Suppl. 5, S456-S464.
22. Strachan DP, Cook DG. Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax 1997; 52: 905-914.
23. Strachan DP, Cook DG. Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax 1998; 53: 204-212.
24. Cook DG, Strachan DP, Carey IM. Health effects of passive smoking. 9. Parental smoking and spirometric indices in children. Thorax 1998; 53: 884-893.
25. Stein RT, Holberg CJ, Sherrill D, et al. Influence of parental smoking on respiratory symptoms during the first decade of life: the Tucson Children's Respiratory Study. Am J Epidemiol 1999; 149: 1030-1037.
26. Floreani AA, Rennard SI. The role of cigarette smoke in the pathogenesis of asthma and as a trigger for acute symptoms. Curr Opin Pulm Med 1999; 5: 38-46.
27. Jaakkola JJ, Gissler M. Maternal smoking in pregnancy, fetal development, and childhood asthma. Am J Public Health 2004; 94: 136-140.
28. Kurukulaaratchy RJ, Fenn M, Twiselton R, Matthews S, Arshad SH. The prevalence of asthma and wheezing illnesses amongst 10-year-old schoolchildren. Respir Med 2002; 96: 163-169.
29. Ehrlich RI, Du Toit D, Jordaan E, et al. Risk factors for childhood asthma and wheezing. Importance of maternal and household smoking. Am J Respir Crit Care Med 1996; 154: 681-688.
30. Gilliland FD, Li YF, Peters JM. Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med 2001; 163: 429-436.
31. Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-1136.
32. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948-968.
33. Alberto R Bioinformatics tools. http://snpper.chip.org. Date last accessed: February 22, 2006.
34. Single Nucleotide Polymorphisms NCBI. www.ncbi.nhn.nih.gov/projects/SNP/. Date last accessed: February 22, 2006.
35. International HapMap project. http://hapmap.org/. Date last accessed: February 22, 2006.
36. Ronaghi M. Pyrosequencing sheds light on DNA sequencing. Genome Res 2001; 11: 3-11.
37. Utting M, Hampe J, Platzer M, Huse K. Locking of 3′ ends of single-stranded DNA templates for improved Pyro-sequencing performance. Biotechniques 2004; 37: 66-67, 70-63.
38. SNP Primer Design from Pyrosequencing. AB version 1.0.1. http://primerdesign-pyrosequencing.com/jsp/TemplateInputjsp. Date last accessed: January 13, 2005.
39. SOP3 version 2. Division of Immunogenetics-Children's Hospital Of Pittsburgh. http://imgen.ccbb.pitt.edu/sop3/. Date last accessed: January 13, 2005.
40. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121-130.
41. Stokes ME, Davis CS, Koch GG. Categorical data analysis using the SAS system. Cary, SAS Institute, 1995.
42. Benjamini Y, Hochberg M. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Royal Stat Soc B 1995; 57: 289-300.
43. Howard TD, Koppelman GH, Xu J, et al. Gene-gene interaction in asthma: IL4RA and IL13 in a Dutch population with asthma. Am J Hum Genet 2002; 70: 230-236.
44. Gabriel SB, Schaffner SF, Nguyen H, et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
45. Mao XQ Kawai M, Yamashita T, et al. Imbalance production between interleukin-1beta (IL-1beta) and IL-1 receptor antagonist (IL-1Ra) in bronchial asthma. Biochem Biophys Res Commun 2000; 276: 607-612.
46. Arshad SH, Hide DW. Effect of environmental factors on the development of allergic disorders in infancy. J Allergy Clin Immunol 1992; 90: 235-241.
47. Arshad SH, Stevens M, Hide DW. The effect of genetic and environmental factors on the prevalence of allergic disorders at the age of two years. Clin Exp Allergy 1993; 23: 504-511.
48. Chan-Yeung M, Dimich-Ward H. Respiratory health effects of exposure to environmental tobacco smoke. Respirology 2003; 8: 131-139.
49. Meyers DA, Postma DS, Stine OC, et al. Genome screen for asthma and bronchial hyperresponsiveness: interactions with passive smoke exposure. J Allergy Clin Immunol 2005; 115: 1169-1175.
50. Colilla S, Nicolae D, Pluzhnikov A, et al. Evidence for gene-environment interactions in a linkage study of asthma and smoking exposure. J Allergy Clin Immunol 2003; 111: 840-846.